All Stories

  1. Leaders in Cardiovascular Research: Salim Yusuf

    Article • Cardiovascular Research, January 2020, Oxford University Press (OUP)

    Prof Tomasz Guzik

  2. E-vaporating benefits of e-vaping

    Article • European Heart Journal, December 2019, Oxford University Press (OUP)

    Prof Tomasz Guzik

  3. High impact Cardiovascular Research: beyond the heart and vessels

    Article • Cardiovascular Research, November 2019, Oxford University Press (OUP)

    Prof Tomasz Guzik

  4. Causal association between periodontitis and hypertension: evidence from Mendelian randomization and a randomized controlled trial of non-surgical periodontal therapy

    Article • European Heart Journal, September 2019, Oxford University Press (OUP)

    Prof Tomasz Guzik

  5. When, where, and how to target vascular inflammation in the post-CANTOS era?

    Article • European Heart Journal, March 2019, Oxford University Press (OUP)

    Prof Tomasz Guzik

  6. Plan S: in Service or Disservice to Society?

    Article • European Heart Journal, February 2019, Oxford University Press (OUP)

    Prof Tomasz Guzik

  7. What matters in Cardiovascular Research? Scientific discovery driving clinical delivery

    Article • Cardiovascular Research, September 2018, Oxford University Press (OUP)

    Prof Tomasz Guzik

  8. OUP accepted manuscript

    Article • Cardiovascular Research, January 2018, Oxford University Press (OUP)

    Prof Tomasz Guzik

  9. The role of infiltrating immune cells in dysfunctional adipose tissue

    Article • Cardiovascular Research, July 2017, Oxford University Press (OUP)

    Prof Tomasz Guzik

  10. Heterogenous treatment effects: secrets for a reliable treat-to-target trial?

    Article • Cardiovascular Research, May 2017, Oxford University Press (OUP)

    Prof Tomasz Guzik

  11. Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in hypertension

    Article • The FASEB Journal, February 2016, Federation of American Societies For Experimental Biology (FASEB)

    Prof Tomasz Guzik